<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-75439</identifier>
<setSpec>1575-0620</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Directly observed anti-retroviral therapy amongst female inmates</dc:title>
<dc:description xml:lang="en">Objectives: It is considered that the gold standard for success in HAART is adherence. To improve adherence amongstinmates with HIV-AIDS, the use of directly observed treatment (DOT) is proposed using the tuberculosis treatment model.Material and methods: HIV positive female patients with ARVT criteria who voluntarily participated were used for thestudy. The initial and final CD4 cell count and HIV viral load were the principal data used for assessment purposes.Results: 52 women with an average age of 34 years were studied, with an average HIV infection time span of between1 and 20 years. Initial CD4 cell count of &lt;100 copies/mL in 16 patients (30.7%) and an equivalent final count in 4 patients(7.6%) were found. Initial undetectable viral loads were not found in any patient, while final undetectable viral loads werefound in 33 (63.4%). 21% of patients had opportunistic infections. The most important of these was tuberculosis, followedby HCV co-infection. The most frequently used ARVT schedule was two NRTI with one NNTRI.Conclusions: The application of DOT strategy to ARVT was effective amongst our patients, as shown by the increasein CD4 counts and the increased number of patients with reductions in viral loads to undetectable levels. While it is a toolthat is not easy to use for cases of chronic treatment, we do consider it to be useful for prison inmates(AU)</dc:description>
<dc:creator>Carolis, L. de</dc:creator>
<dc:creator>Wainstein, C</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivos: La adherencia al tratamiento antirretroviral de alta eficacia (TARV) se considera el gold standard para el éxitodel mismo. Para mejorar la adherencia en persona privadas de libertad viviendo con VIH-Sida, se propuso la utilizacióndel tratamiento directamente observado tomando el modelo para el tratamiento de la tuberculosis.Material y métodos: se incluyeron las mujeres VIH positivas con criterios de TARV que voluntariamente decidieronparticipar. Los datos principales a evaluar fueron control inicial y final de CD4 y carga viral para VIH.Resultados: estudiamos 52 mujeres, edad promedio 34 años, entre 1 y 20 años de infección VIH. CD4 menor a 100 cél/mlinicial en 16 pacientes (30.7%) y final en 4 pacientes (7.6%). Carga viral indetectable inicial en ninguna paciente y final en 33pacientes (63.4%) 21 % con infecciones oportunistas, principal tuberculosis. 17% coinfectadas con HCV. El esquema de TARVmás utilizado fue 2 INTR más 1 INNTR.Conclusiones: La estrategia DOT aplicada al TARV fue efectiva en nuestras pacientes, evidenciado por el aumento delos CD4 y el mayor número de pacientes con disminución de la carga viral hasta permanecer indetectables. Si bien es difícilde implementar en tratamientos crónicos consideramos que es una herramienta útil para personas privadas de libertad(AU)</dc:description>
<dc:source>Rev. esp. sanid. penit;11(3): 68-72, feb.-nov. 2009. ilus</dc:source>
<dc:identifier>ibc-75439</dc:identifier>
<dc:title xml:lang="es">Terapia antirretroviral directamente observada en mujeres privadas de libertad</dc:title>
<dc:subject>^d24719</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d24718^s22057</dc:subject>
<dc:subject>^d35395^s22074</dc:subject>
<dc:subject>^d38332^s22073</dc:subject>
<dc:subject>^d33075^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d29499</dc:subject>
<dc:subject>^d11766^s22083</dc:subject>
<dc:type>article</dc:type>
<dc:date>200911</dc:date>
</metadata>
</record>
</ibecs-document>
